, /PRNewswire/ -- The global DNA sequencing market size is estimated to grow by .34 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 20.
01% during the forecast period. Growing adoption of ngs is driving market growth, with a trend towards emergence of third-generation sequencing methods. However, inadequate resources for dna sequencing in developing countries poses a challenge.
Key market players include 10X Genomics Inc., Abbott Laboratories, Agilent Technologies Inc., Azenta Inc.
, and Co., BGI Genomics Co. Ltd.
, Bio Rad Laboratories Inc., Danaher Corp., Eurofins Scientific SE, F.
Hoffmann La Roche Ltd., Illumina Inc., Laboratory Corp.
of America Holdings, Macrogen Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc.
, QIAGEN NV, SeqLL Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc..
Get a detailed analysis on regions, market segments, customer landscape, and companies - The DNA sequencing market is experiencing significant growth due to the emergence of third-generation sequencing technology. This advanced method reads DNA at the single-molecule level, eliminating the need for clonal amplification and preparative steps. Third-generation sequencing offers long-reads, whole-transcript sequencing, and epigenetic modification detection.
Challenges, such as accuracy issues, are being addressed through research and engineering solutions. Vendors are investing in third-generation sequencing R&D to expa.